Decoding 11 Analyst Evaluations For Jazz Pharmaceuticals
Decoding 11 Analyst Evaluations For Jazz Pharmaceuticals
破解11位分析师对爵士制药的评估
A comprehensive examination...Throughout the last three months, 11 analysts have evaluated Jazz Pharmaceuticals (NASDAQ:JAZZ), offering a diverse set of opinions from bullish to bearish.
在过去的三个月里，11名分析师针对Jazz Pharmaceuticals（纳斯达克代码：JAZZ）进行了评估，提出了从看好到看淡不一的不同观点。
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
下表提供了他们最近的评级快照，展示了情绪在过去30天中的演变情况，并将其与之前的月份进行比较。
In the assessment of 12-month price targets, analysts unveil insights for Jazz Pharmaceuticals, presenting an average target of $163.73, a high estimate of $210.00, and a low estimate of $113.00. A 4.25% drop is evident in the current average compared to the previous average price target of $171.00.
在对12个月价格目标的评估中，分析师揭示了针对 Jazz Pharmaceuticals 的见解，呈现出一个平均目标价格为163.73美元，一个最高估价为210美元和一个最低估价为113美元。与先前的平均目标价格171.00美元相比，目前平均目标呈4.25％下降。
Analyzing Analyst Ratings: A Detailed Breakdown
分析分析师评级：详细剖析
A comprehensive examination...
最近的...
登录免费看全文
登录/注册